Healthcare associated infections by multidrug resistant in pediatric intensive care: Analysis of four years.
AbstractObjective: To report healthcare associated infections (HAI) in intensive care units of children, caused by multidrug resistant bacteria, and measures to control them. Methods: a retrospective descriptive study of all HAI in three pediatric intensive care units and one neonatal intensive care unit of Prontobaby Hospital da Criança, Rio de Janeiro, Brazil. Results: Between 2009 and 2012 we had 36,883 patients-days which 10,442 were from NICU and 26,441 from the PICUs. We reported 482 healthcare-related infections (109 from NICU and 373 from PICU). Gram negative bacteria were the most prevalent group, also in NICU (22.9%) as in PICU (35.9%). The rates of multiresistant Gram positive bacteria (MRSA and CoNS multiresistant) of HAI in the PICUs and NICU were 22% (22/100) and 13,6% (3/22) respectively. The rates of multiresistant Gram negative bacteria (ESBL group, P.aeruginosa resistant to carbapenem, Acinetobacter sp multiresistant, B.cepaciae and S. maltophilia) in PICUs and NICU were 49,3% (66/134) and 56% (14/25) respectively. Ventilator-associated pneumonia was the most common type of infection (incidence density rate of 7,0 per 1000 VM-days) in PICU. A bundle of measures (training of team assistance, oral chlorexidine to all intubated children and use of bacteriological filters in expiration phase) was implemented in the two last years of study and reduced the number of VAP to 2,2 per 1000 VM-days. Conclusion: We found higher rates of multiresistant Gram negative bacteria also in PICU as NICU and a bundle of measures to control VAP in PICU was a well done intervention.
Copyright conditions: Copyright on any research article in the International Journal of Infection Control (IJIC) is retained by the author(s). Authors grant IJIC permission to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. IJIC conforms to the Creative Commons Attribution License (http://creativecommons.org) as terms and conditions of publishing research articles. In summary, anyone is free: • to copy, distribute, and display the work; • to make derivative works; • to make commercial use of the work; as long as: • the original author must be given credit; • for any reuse or distribution, it must be made clear to others what the license terms of this work are; • any of these conditions can be waived if the authors gives permission. Statutory fair use and other rights are in no way affected by the above. Authors' certification: In submitting a manuscript to IJIC, authors are requested to certify that: • They are authorized by their co-authors to enter into these arrangements. • They warrant, on behalf of themselves and their co-authors, that: o the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights; o they are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to IJIC are not in breach of any other obligation. If the law requires that the article be published in the public domain, they will notify IJIC at the time of submission; o the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy; o they have taken due care to ensure the integrity of the article.